Of note, within the T2D group, we have also tested donors that had developed single T1D-associated antibodies against insulin (mIAA; n = 10, mean age = 47; Supplementary Table S1), most likely in response to subcutaneous insulin injection, as all T2D-IAA+ donors had received insulin therapy before or during hospitalization. Here, INS is linked to type 1 diabetes mellitus.